{rfName}
TR

Indexado en

Licencia y uso

Citaciones

Altmetrics

Análisis de autorías institucional

Llimós-Aubach JAutor o CoautorPujol-Coma AAutor o CoautorCastellanos AAutor o CoautorBahamonde MiAutor o CoautorComes NAutor o CoautorCallejo GAutor o CoautorGasull XAutor o Coautor
Compartir
Publicaciones
>
Artículo pendiente de publicación

TRESK background potassium channel regulates MrgprA3 + pruriceptor excitability, acute and chronic itch.

Publicado en:Pain. - 2025-03-06 (), DOI: 10.1097/j.pain.0000000000003540

Autores: Llimós-Aubach J; Andres-Bilbe A; Pujol-Coma A; Castellanos A; Pallás I; Bahamonde MI; de Anta JM; Soler C; Comes N; Callejo G; Gasull X

Afiliaciones

Department of Pathology and Experimental Therapy, School of Medicine, Universitat de Barcelona, Barcelona, Spain. - Autor o Coautor
Neurophysiology Laboratory, Department of Biomedicine, Medical School, Institute of Neurosciences, Universitat de Barcelona, Barcelona, Spain. - Autor o Coautor

Resumen

A subset of peripheral sensory neurons expressing specific Mas-related G-protein-coupled receptors and transient receptor potential channels mediate pruritogen-induced chemical itch. However, the molecular mechanisms that regulate the excitability of these cells, and consequently itch sensation, are poorly understood. TWIK-related spinal cord K + channel (TRESK) is a background K + channel that modulates the resting membrane potential, action potential firing, and neuronal excitability, and it has been involved in somatosensation and pain transduction. Here, we demonstrate that this channel contributes to pruritic transduction and it is a potential target for treating chronic itch pathologies. TRESK channel coexpress with Mas-related G-protein-coupled receptor A3, MrgprC11 and MrgprD in mouse sensory neurons, and with MrgprX1 in human ones. Genetic ablation of TRESK enhances firing of MrgprA3-expressing pruriceptors and acute itch in response to intradermal injection of chloroquine, while the response to histamine, BAM8-22, or leukotriene C4 remains unaffected. TRESK deletion also exacerbates chronic itch in mouse models of allergic contact dermatitis, dry skin, and imiquimod-induced psoriasiform dermatitis, resulting in a significantly increased scratching behavior that develops earlier and is more robust. Moreover, pharmacologically enhancing TRESK function diminishes both acute and chronic itch in wild-type mice but not in TRESK knockout (KO) animals. In summary, our data indicate that TRESK plays a role in regulating the excitability of a subset of sensory neurons that mediate histaminergic-independent itch. Enhancing the channel function with specific activators represents a promising antipruritic therapeutic approach that can be combined with other compounds for the treatment of nonhistaminergic itch, which currently lack adequate treatment options.

Palabras clave
AnesthesiologyAnesthesiology and pain medicineBiotecnologíaCiências biológicas iCiências biológicas iiCiências biológicas iiiCiencias socialesClinical neurologyEducação físicaEnfermagemFarmaciaGeneral medicineInterdisciplinarMedicina iMedicina iiMedicina iiiMedicine (all)NeurologyNeurology (clinical)NeurosciencesOdontologíaPharmacologyPsicologíaPsychologySaúde coletiva

Indicios de calidad

Impacto bibliométrico. Análisis de la aportación y canal de difusión

El trabajo ha sido publicado en la revista Pain debido a la progresión y el buen impacto que ha alcanzado en los últimos años, según la agencia WoS (JCR), se ha convertido en una referencia en su campo. En el año de publicación del trabajo, 2025, se encontraba en la posición 34/310, consiguiendo con ello situarse como revista Q1 (Primer Cuartil), en la categoría Neurosciences.

Análisis de liderazgo de los autores institucionales

Existe un liderazgo significativo ya que algunos de los autores pertenecientes a la institución aparecen como primer o último firmante, se puede apreciar en el detalle: Primer Autor (Llimós Aubach, Júlia) y Último Autor (Gasull Casanova, Xavier).